Owner Alnylam Pharmaceuticals, Inc.

Inventors Vornlocher, Hans-Peter; Hadwiger, Philipp; De Fougerolles, Antonin; Akinc, Akin

Agent Griffith Hack

Pub. Number AU-B-2006261732

PCT Pub. Number WO2007/002718

Priority 60/694,382 27.06.05 US

Filing date 27 June 2006

Wipo publication date 4 January 2007

Acceptance publication date 15 September 2011

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/88 (2006.01) Mutation or genetic engineering

C12P 19/34 (2006.01) Preparation of compounds containing saccharide radicals

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids